GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neutra NTRR · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 3 Nov 2026, in USD

About Neutra

From its filings with the US Securities and Exchange Commission

SEC filings

Neutra is based in Houston, Texas and is incorporated in Wyoming. Its shares trade on OTC under the ticker NTRR. The SEC classifies its business as medicinal chemicals & botanical products. In the fiscal year to 31 January 2023, it reported revenue of $67,996 and a net loss of $561,417. At that date it held total assets of $75,175 and shareholders' equity of −$773,820.

Read the filing on SEC.gov ↗

Company facts

Sector
N/A
Industry
N/A
Listed since
12 Jul 2011
Head office
2500 CITYWEST BLVD., HOUSTON, TX, 77042
Incorporated in
WY
Classification
Medicinal Chemicals & Botanical Products
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Sydney JimPresident, Principal Executive Officer, Treasurer, Company Secretary, since 2013$100,000
  • Mr. Daniel ChenDirector
  • Mr. Gilbert FungDirector
  • Mr. Cole MungerDirector
  • Mr. Amar RavalDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Neutra Corp engages in research and development of modern healthy living solutions.
  • The firm markets products derived from all natural and organic origins.
  • Subsidiaries include Diamond Anvil Designs, LLC, Deity Corporation and Vivis Corporation.

Weaknesses

  • The company entrusts manufacturing to a nutraceutical contractor for private labeling.
  • Neutra Corp sells hemp-derived products containing delta-8-THC and other cannabinoids.
  • The firm plans to research new technology for the Nutraceutical space.

Opportunities

  • The firm is primarily focused on participating in the medical cannabis market.
  • Neutra Corp intends to bring new technology to the Nutraceutical space.
  • The company sells products under its own brand via private labeling.

Threats

  • Neutra Corp operates in the competitive nutraceutical space with organic origins.
  • The firm sells hemp-derived products containing delta-8-THC and other cannabinoids.
  • Neutra Corp went IPO on 12 July 2011 in the US.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.